HUE049387T2 - A halichondrin B analógjainak szintézisében hasznos makrociklizációs reakciók és köztitermékek - Google Patents

A halichondrin B analógjainak szintézisében hasznos makrociklizációs reakciók és köztitermékek

Info

Publication number
HUE049387T2
HUE049387T2 HUE14858240A HUE14858240A HUE049387T2 HU E049387 T2 HUE049387 T2 HU E049387T2 HU E14858240 A HUE14858240 A HU E14858240A HU E14858240 A HUE14858240 A HU E14858240A HU E049387 T2 HUE049387 T2 HU E049387T2
Authority
HU
Hungary
Prior art keywords
halichondrin
analogs
synthesis
intermediates useful
macrocyclization reactions
Prior art date
Application number
HUE14858240A
Other languages
English (en)
Hungarian (hu)
Inventor
Francis Fang
Dae-Shik Kim
Hyeong-Wook Choi
Charles Chase
Jaemoon Lee
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of HUE049387T2 publication Critical patent/HUE049387T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/28Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
HUE14858240A 2013-11-04 2014-11-04 A halichondrin B analógjainak szintézisében hasznos makrociklizációs reakciók és köztitermékek HUE049387T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361899697P 2013-11-04 2013-11-04

Publications (1)

Publication Number Publication Date
HUE049387T2 true HUE049387T2 (hu) 2020-09-28

Family

ID=53005318

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE14858240A HUE049387T2 (hu) 2013-11-04 2014-11-04 A halichondrin B analógjainak szintézisében hasznos makrociklizációs reakciók és köztitermékek

Country Status (12)

Country Link
US (5) US9783549B2 (enExample)
EP (2) EP3066102B1 (enExample)
JP (3) JP6625533B2 (enExample)
CN (3) CN109942560B (enExample)
BR (1) BR112016009452B1 (enExample)
CA (1) CA2929084C (enExample)
ES (1) ES2787603T3 (enExample)
HU (1) HUE049387T2 (enExample)
IL (4) IL244694B (enExample)
RU (1) RU2710545C2 (enExample)
SG (1) SG11201603490TA (enExample)
WO (1) WO2015066729A1 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE45324E1 (en) 2004-06-03 2015-01-06 Eisai R&D Management Co., Ltd. Intermediates for the preparation of analogs of halichondrin B
MX2010003599A (es) 2007-10-03 2010-09-10 Eisai R&D Man Co Ltd Intermediarios y metodos para la sintesis de analogos de halicondrina b.
US8598373B2 (en) 2008-04-04 2013-12-03 Eisai R&D Management Co., Ltd. Halichondrin B analogs
MX2012008510A (es) 2010-01-26 2012-11-21 Eisai R&D Man Co Ltd Derivados de furo [3, 2-b] pirano utiles en la sintesis de analogos de halicondrina b.
CN109942560B (zh) * 2013-11-04 2022-06-17 卫材R&D管理有限公司 软海绵素b的类似物合成中有用的大环化反应和中间体
EP3505520A1 (en) 2013-12-06 2019-07-03 Eisai R&D Management Co., Ltd. Methods useful in the synthesis of halichondrin b analogs
WO2016003975A1 (en) 2014-06-30 2016-01-07 President And Fellows Of Harvard College Synthesis of halichondrin analogs and uses thereof
US10344038B2 (en) 2015-04-30 2019-07-09 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
MX392296B (es) 2015-05-07 2025-03-24 Eisai R&D Man Co Ltd Reacciones de macrociclizacion e intermediarios y otros fragmentos utiles en la sintesis de macrolidos de halicondrina.
WO2017064627A2 (en) * 2015-10-14 2017-04-20 Dr. Reddy's Laboratories Limited Process for preparation of eribulin and intermediates thereof
SG11201806133UA (en) * 2016-02-12 2018-08-30 Eisai R&D Man Co Ltd Intermediates in the synthesis of eribulin and related methods of synthesis
CN114191563A (zh) 2016-03-02 2022-03-18 卫材研究发展管理有限公司 基于艾日布林的抗体-药物偶联物和使用方法
EP3478691A4 (en) * 2016-06-30 2020-07-22 Eisai R&D Management Co., Ltd. REACTION OF PRINS AND USEFUL INTERMEDIARIES IN THE SYNTHESIS OF HALICHONDRIN MACROLIDES AND ITS ANALOGUES
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
ES2931533T3 (es) 2017-04-05 2022-12-30 Harvard College Compuesto macrocíclico y usos del mismo
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
WO2018217894A1 (en) * 2017-05-24 2018-11-29 Eisai R&D Management Co., Ltd. Fluorine-labelled halichondrin derivatives and related methods of synthesis
CN111433211B (zh) 2017-07-06 2024-05-07 哈佛大学的校长及成员们 软海绵素的合成
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
CN109694379B (zh) * 2017-10-24 2020-09-11 江苏恒瑞医药股份有限公司 用于制备艾日布林的中间体及其制备方法
WO2019093776A1 (ko) * 2017-11-09 2019-05-16 연성정밀화학(주) 에리불린 메실산염의 제조 중간체 및 그의 제조방법
EP4403560A3 (en) 2017-11-15 2024-10-23 President And Fellows Of Harvard College Macrocyclic compounds and uses thereof
US11419856B2 (en) 2017-11-20 2022-08-23 Basilea Pharmaceutica International AG Pharmaceutical combinations for use in the treatment of neoplastic diseases
CN109970822B (zh) * 2017-12-27 2023-03-28 上海科胜药物研发有限公司 一种合成埃格列净中间体的制备方法
CN111868044B (zh) 2018-01-03 2024-07-19 卫材R&D管理有限公司 可用于合成软海绵素大环内酯及其类似物的普林斯反应和化合物
EP3608323B1 (en) * 2018-03-02 2021-11-03 Beijing Tienyi Lufu Pharmatech Co. Ltd. Pyran fused ring compound, preparation method therefor and use thereof
WO2019211877A1 (en) * 2018-05-03 2019-11-07 Cipla Limited Process for the preparation of macrocyclic ketone analogs of halichondrin b
US20210260023A1 (en) * 2018-07-20 2021-08-26 Dr. Reddy's Laboratories Limited Purification process for preparation of eribulin and intermediates thereof
US11447499B2 (en) * 2019-06-14 2022-09-20 Rk Pharma Inc. Process for the preparation of eribulin mesylate intermediate
CN110684036B (zh) * 2019-11-22 2022-04-12 江苏慧聚药业股份有限公司 一条制备甲磺酸艾日布林的方法
WO2023144733A1 (en) * 2022-01-26 2023-08-03 Simon Fraser University Compounds and processes for the preparation of eribulin
WO2024021261A1 (zh) * 2022-07-29 2024-02-01 上海皓元医药股份有限公司 一种艾日布林中间体的制备方法

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107206A (en) 1974-04-08 1978-08-15 Akzona Incorporated Benzo-bicyclononene- derivatives
SU652180A1 (ru) 1975-12-16 1979-03-15 Краснодарский политехнический институт 1(Фурил-2,)-2-(2-,, формилфурил-5,, ) этилен или его метильное производное как промежуточный продукт дл синтеза фуран-2,5-дикарбоновой кислоты и способ его получени
US5338865A (en) 1992-03-12 1994-08-16 President And Fellows Of Harvard College Synthesis of halichondrin B and norhalichondrin B
US5436238A (en) 1992-03-12 1995-07-25 President And Fellows Of Harvard College Halichondrins and related compounds
GB9206244D0 (en) 1992-03-23 1992-05-06 Pharma Mar Sa Cytotoxic compound from a marine sponge
TW255880B (enExample) 1992-09-09 1995-09-01 Hoechst Ag
WO1998009942A1 (en) 1996-09-06 1998-03-12 Eli Lilly And Company Catalytic selective sulfonylation process
US6870058B2 (en) 1996-12-03 2005-03-22 The Trustees Of The University Of Pennsylvania Compounds which mimic the chemical and biological properties of discodermolide
US6653341B1 (en) 1998-06-17 2003-11-25 Eisai Co., Ltd. Methods and compositions for use in treating cancer
CN1216051C (zh) 1998-06-17 2005-08-24 卫材株式会社 大环类似物及其使用和制备的方法
US8097648B2 (en) 1998-06-17 2012-01-17 Eisai R&D Management Co., Ltd. Methods and compositions for use in treating cancer
DE10106647A1 (de) 2001-02-12 2002-08-22 Univ Hannover Ratjadon-Derivate zum Hemmen des Zellwachstums
CN109180615A (zh) * 2004-06-03 2019-01-11 卫材R&D管理有限公司 用于制备软海绵素b的类似物的中间体
USRE45324E1 (en) 2004-06-03 2015-01-06 Eisai R&D Management Co., Ltd. Intermediates for the preparation of analogs of halichondrin B
US20060045846A1 (en) * 2004-08-30 2006-03-02 Horstmann Thomas E Reagents and methods for labeling terminal olefins
EP1831697A4 (en) 2004-12-09 2011-01-26 Eisai R&D Man Co Ltd SCREENING OF TUBULIN ISOTYPE IN CANCER THERAPY USING ANALOGUES OF HALICHONDRIN B
US7915457B2 (en) 2005-09-26 2011-03-29 Symrise Gmbh & Co. Kg Intramolecular Prins reaction and catalysts suitable therefor
WO2008010776A1 (en) * 2006-07-21 2008-01-24 Agency For Science, Technology And Research Aigialomycin d and derivatives thereof and their use in treating cancer or malaria or a microbial infection
JPWO2009014105A1 (ja) 2007-07-20 2010-10-07 株式会社山田養蜂場本社 新規カルボン酸およびそれを有効成分とする抗うつ用組成物
MX2010003599A (es) * 2007-10-03 2010-09-10 Eisai R&D Man Co Ltd Intermediarios y metodos para la sintesis de analogos de halicondrina b.
WO2009064029A1 (en) 2007-11-16 2009-05-22 Eisai R & D Management Co., Ltd. Novel intermediate for halichondrin b analog synthesis and novel desulfonylation reaction used for the intermediate
US8598373B2 (en) 2008-04-04 2013-12-03 Eisai R&D Management Co., Ltd. Halichondrin B analogs
JP5371091B2 (ja) 2009-01-23 2013-12-18 三菱レイヨン株式会社 モノスルホン酸エステルの製造方法
MX2012008510A (es) 2010-01-26 2012-11-21 Eisai R&D Man Co Ltd Derivados de furo [3, 2-b] pirano utiles en la sintesis de analogos de halicondrina b.
WO2012147900A1 (en) 2011-04-28 2012-11-01 Eisai R&D Management Co., Ltd. Microreactor process for halichondrin b analog synthesis
WO2013078559A1 (en) * 2011-11-30 2013-06-06 Alphora Research Inc. Process for preparation of (3r)-2,4-di-leaving group-3-methylbut-1-ene
US9278979B2 (en) 2012-03-30 2016-03-08 Alphora Research Inc. Synthetic process for preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful therein
WO2015000070A1 (en) 2013-07-03 2015-01-08 Alphora Research Inc. Synthetic process for preparation of macrocyclic c1-keto analogs of halichondrin b and intermediates useful therein including intermediates containing -so2-(p-tolyl) groups
CN109942560B (zh) * 2013-11-04 2022-06-17 卫材R&D管理有限公司 软海绵素b的类似物合成中有用的大环化反应和中间体
EP3505520A1 (en) * 2013-12-06 2019-07-03 Eisai R&D Management Co., Ltd. Methods useful in the synthesis of halichondrin b analogs
WO2016038624A1 (en) 2014-09-09 2016-03-17 Cipla Limited "process for the preparation of macrocyclic ketone analogs of halichondrin b or pharmaceutically acceptable salts and intermediates thereof"
US10344038B2 (en) * 2015-04-30 2019-07-09 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
MX392296B (es) 2015-05-07 2025-03-24 Eisai R&D Man Co Ltd Reacciones de macrociclizacion e intermediarios y otros fragmentos utiles en la sintesis de macrolidos de halicondrina.
SG11201806133UA (en) 2016-02-12 2018-08-30 Eisai R&D Man Co Ltd Intermediates in the synthesis of eribulin and related methods of synthesis
EP3478691A4 (en) 2016-06-30 2020-07-22 Eisai R&D Management Co., Ltd. REACTION OF PRINS AND USEFUL INTERMEDIARIES IN THE SYNTHESIS OF HALICHONDRIN MACROLIDES AND ITS ANALOGUES
US20180009825A1 (en) * 2016-07-06 2018-01-11 Apicore Us Llc Methods of making eribulin mesylate
WO2018217894A1 (en) 2017-05-24 2018-11-29 Eisai R&D Management Co., Ltd. Fluorine-labelled halichondrin derivatives and related methods of synthesis
CN111868044B (zh) 2018-01-03 2024-07-19 卫材R&D管理有限公司 可用于合成软海绵素大环内酯及其类似物的普林斯反应和化合物

Also Published As

Publication number Publication date
IL244694B (en) 2019-07-31
EP3689881B1 (en) 2022-01-12
RU2016121648A (ru) 2017-12-08
CN105683198B (zh) 2019-03-12
IL288468B2 (en) 2023-02-01
BR112016009452B1 (pt) 2022-06-07
JP2020059728A (ja) 2020-04-16
IL275240B (en) 2022-01-01
IL288468A (en) 2022-01-01
RU2710545C2 (ru) 2019-12-27
US20160264594A1 (en) 2016-09-15
EP3066102B1 (en) 2020-02-26
US10221189B2 (en) 2019-03-05
US9783549B2 (en) 2017-10-10
CN109942560B (zh) 2022-06-17
IL288468B (en) 2022-10-01
US20210188867A1 (en) 2021-06-24
IL275240A (en) 2020-07-30
EP3689881A1 (en) 2020-08-05
BR112016009452A8 (pt) 2020-03-24
ES2787603T3 (es) 2020-10-16
US20200223864A1 (en) 2020-07-16
JP6625533B2 (ja) 2019-12-25
JP6909840B2 (ja) 2021-07-28
CN114716453A (zh) 2022-07-08
CN109942560A (zh) 2019-06-28
SG11201603490TA (en) 2016-05-30
US10934307B2 (en) 2021-03-02
US20180002342A1 (en) 2018-01-04
US10611773B2 (en) 2020-04-07
CA2929084C (en) 2022-01-11
JP6889232B2 (ja) 2021-06-18
IL267936B (en) 2020-06-30
CN105683198A (zh) 2016-06-15
RU2016121648A3 (enExample) 2018-08-06
EP3066102A1 (en) 2016-09-14
IL244694A0 (en) 2016-04-21
US11643418B2 (en) 2023-05-09
US20190144463A1 (en) 2019-05-16
EP3066102A4 (en) 2017-04-26
JP2020023521A (ja) 2020-02-13
IL267936A (en) 2019-09-26
WO2015066729A1 (en) 2015-05-07
JP2016536316A (ja) 2016-11-24
CA2929084A1 (en) 2015-05-07

Similar Documents

Publication Publication Date Title
IL288468A (en) Microcyclization reactions and useful intermediates in the synthesis of helichondrin b analogs
IL281275A (en) Useful methods in the synthesis of analogues of licondrin B
IL276376B (en) Macrocyclization Reactions and Other Useful Intermediates and Parts in the Synthesis of Helicondrin Macrolides
ZA201408429B (en) Methods for the synthesis of ethylfumarates and their use as intermediates
GB201421334D0 (en) Synthesis of aeizeolite
EP2828275A4 (en) SYNTHESIS OF 3-O-FUCOSYLLACTOSE TYPE TRISACCHARIDE AND ITS INTERMEDIATES
HUE071721T2 (hu) Bõrtisztító
ZA201505860B (en) Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
IL288460A (en) Prince's reaction and useful intermediates in the synthesis of helicondrin macrolides and their analogs
IL244084A0 (en) New derivatives of onzialamycin and methods for their synthesis
EP3160970A4 (en) Synthesis of halichondrin analogs and uses thereof
PT3071247T (pt) Dispositivo para a construção de pele
IL245771A0 (en) Synthesis and compositions of porphyrin compounds
GB201218352D0 (en) Compounds and their synthesis
EP2970319A4 (en) 6-ACETYLMORPHINE ANALOGUE AND METHOD FOR THE SYNTHESIS AND USE
IL246258A0 (en) Synthesis of an enantiomer of progesterone and its intermediates
ZA201506787B (en) Synthesis of ent-progesterone and intermediates thereof
GB201320732D0 (en) Methods of chemical synthesis
GB201321380D0 (en) Analysis and synthesis flexi-unit
GB201322922D0 (en) Synthesis of Polyoxometalates
GB201309947D0 (en) Personal hygiene apparatus
GB201310660D0 (en) Synthesis of nucleosides
GB201322704D0 (en) Synthesis
GB201313605D0 (en) Novel compounds and their use
GB201218043D0 (en) The personal assistant